Exploring the Correlation between LC–MS Multi-Attribute Method and Conventional Chromatographic Product Quality Assays through Multivariate Data Analysis

Senior M. Fresh from the biotech pipeline: fewer approvals, but biologics gain share. Nat Biotechnol. 2023. https://doi.org/10.1038/s41587-022-01630-6.

Article  PubMed  PubMed Central  Google Scholar 

Reichert JM. Antibodies to watch in 2017. Mabs-Austin. 2017;9(2):167–81. https://doi.org/10.1080/19420862.2016.1269580.

Article  CAS  Google Scholar 

Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol. 2022;40(12):1722–60. https://doi.org/10.1038/s41587-022-01582-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies. 2020;9(3):ARTN 34. https://doi.org/10.3390/antib9030034.

Article  CAS  Google Scholar 

Yasunaga M. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Semin Cancer Biol. 2020;64:1–12. https://doi.org/10.1016/j.semcancer.2019.06.001.

Article  CAS  PubMed  Google Scholar 

Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):ARTN 1. https://doi.org/10.1186/s12929-019-0592-z.

Article  CAS  Google Scholar 

Walsh G. Post-translational modifications of protein biopharmaceuticals. Drug Discov Today. 2010;15(17–18):773–80. https://doi.org/10.1016/j.drudis.2010.06.009.

Article  CAS  PubMed  Google Scholar 

Gao XL, Rawal B, Wang Y, Li XW, Wylie D, Liu YH, et al. Targeted host cell protein quantification by LC-MRM enables biologics processing and product characterization. Anal Chem. 2020;92(1):1007–15. https://doi.org/10.1021/acs.analchem.9b03952.

Article  CAS  PubMed  Google Scholar 

Robinson CJ, Jones C. Quality control and analytical techniques for biopharmaceuticals. Bioanalysis. 2011;3(1):81–95. https://doi.org/10.4155/Bio.10.161.

Article  CAS  PubMed  Google Scholar 

Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discov. 2012;11(7):527–40. https://doi.org/10.1038/nrd3746.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demmon S, Bhargava S, Ciolek D, Halley J, Jaya N, Joubert MK, et al. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies. Biologicals. 2020;67:9–20. https://doi.org/10.1016/j.biologicals.2020.06.008.

Article  PubMed  Google Scholar 

Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771–83. https://doi.org/10.1208/s12248-014-9598-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nat Biotechnol. 2009;27(1):26–34. https://doi.org/10.1038/nbt0109-26.

Article  CAS  PubMed  Google Scholar 

Yu LX. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm Res. 2008;25(4):781–91. https://doi.org/10.1007/s11095-007-9511-1.

Article  CAS  PubMed  Google Scholar 

Yang F, Zhang J, Buettner A, Vosika E, Sadek M, Hao ZQ, et al. Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control. Mabs-Austin. 2023;15(1):Artn 219766810. https://doi.org/10.1080/19420862.2023.2197668.

Article  CAS  Google Scholar 

Zhao SS, Chen DDY. Applications of capillary electrophoresis in characterizing recombinant protein therapeutics. Electrophoresis. 2014;35(1):96–108. https://doi.org/10.1002/elps.201300372.

Article  CAS  PubMed  Google Scholar 

Valliere-Douglass J, Wallace A, Balland A. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions. J Chromatogr A. 2008;1214(1–2):81–9. https://doi.org/10.1016/j.chroma.2008.10.078.

Article  CAS  PubMed  Google Scholar 

Sandra K, Vandenheede I, Sandra P. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. J Chromatogr A. 2014;1335:81–103. https://doi.org/10.1016/j.chroma.2013.11.057.

Article  CAS  PubMed  Google Scholar 

Du Y, Walsh A, Ehrick R, Xu W, May K, Liu HC. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. Mabs-Austin. 2012;4(5):578–85. https://doi.org/10.4161/mabs.21328.

Article  Google Scholar 

Fekete S, Guillarme D, Sandra P, Sandra K. Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals. Anal Chem. 2016;88(1):480–507. https://doi.org/10.1021/acs.analchem.5b04561.

Article  CAS  PubMed  Google Scholar 

Wang Y, Li XJ, Liu YH, Richardson D, Li HJ, Shameem M, Yang XY. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion. Mabs-Austin. 2016;8(8):1477–86. https://doi.org/10.1080/19420862.2016.1226715.

Article  CAS  Google Scholar 

Rogstad S, Faustino A, Ruth A, Keire D, Boyne M, Park J. A Retrospective evaluation of the use of mass spectrometry in FDA biologics license applications. J Am Soc Mass Spectr. 2017;28(5):786–94. https://doi.org/10.1007/s13361-016-1531-9.

Article  CAS  Google Scholar 

Li XW. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing. J Pharmaceut Biomed. 2023;234:ARTN 115581. https://doi.org/10.1016/j.jpba.2023.115581.

Article  CAS  Google Scholar 

Jiang TT, Edwards N, Sukumar N, Mayers M, Higgins J, Kosanam H. Development and validation of LC-MS/MS method for quantification of protease inhibitor Pepstatin A to monitor its robust clearance in vaccine downstream process. J Chromatogr B. 2023;1215:ARTN 123589. https://doi.org/10.1016/j.jchromb.2022.123589.

Article  CAS  Google Scholar 

Rogers RS, Nightlinger NS, Livingston B, Campbell P, Bailey R, Balland A. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. Mabs-Austin. 2015;7(5):881–90. https://doi.org/10.1080/19420862.2015.1069454.

Article  CAS  Google Scholar 

Ren D. Advancing Mass Spectrometry Technology in cGMP Environments. Trends Biotechnol. 2020;38(10):1051–3. https://doi.org/10.1016/j.tibtech.2020.06.007.

Article  CAS  PubMed  Google Scholar 

Rogers RS, Abernathy M, Richardson DD, Rouse JC, Sperry JB, Swann P, et al. A view on the importance of “Multi-Attribute Method” for measuring purity of biopharmaceuticals and improving overall control strategy. AAPS J. 2018;20(1):ARTN 7. https://doi.org/10.1208/s12248-017-0168-3.

Article  CAS  Google Scholar 

Li XW, Pierson NA, Hua XQ, Patel BA, Olma MH, Strulson CA, et al. Analytical performance evaluation of identity, quality-attribute monitoring and new peak detection in a platform multi-attribute method using Lys-C digestion for characterization and quality control of therapeutic monoclonal antibodies. J Pharm Sci-Us. 2023;112(3):691–9. https://doi.org/10.1016/j.xphs.2022.10.018.

Article  CAS  Google Scholar 

Liu Y, Fernandez J, Pu Z, Zhang H, Cao L, Aguilar I, et al. Simultaneous monitoring and comparison of multiple product quality attributes for cell culture processes at different scales using a LC/MS/MS based multi-attribute method. J Pharm Sci-Us. 2020;109(11):3319–29. https://doi.org/10.1016/j.xphs.2020.07.029.

Article  CAS  Google Scholar 

Hines AR, Edgeworth M, Devine PWA, Shepherd S, Chatterton N, Turner C, et al. Multi-attribute monitoring method for process development of engineered antibody for site-specific conjugation. J Am Soc Mass Spectr. 2023;34(7):1330–41.

Comments (0)

No login
gif